FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387047007: Loteprednol etabonate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1763813019 Loteprednol etabonate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1776051014 Loteprednol etabonate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
821621000172114 lotéprednol etabonate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Loteprednol etabonate (substance) Is a Adrenal cortex hormone false Inferred relationship Some
Loteprednol etabonate (substance) Is a Glucocorticoid hormone false Inferred relationship Some
Loteprednol etabonate (substance) Is a Loteprednol (substance) false Inferred relationship Some
Loteprednol etabonate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Loteprednol (substance) true Inferred relationship Some
Loteprednol etabonate (substance) Is a Synthetic glucocorticoid false Inferred relationship Some
Loteprednol etabonate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Androgen receptor agonist (disposition) false Inferred relationship Some
Loteprednol etabonate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonadal hormone false Inferred relationship Some
Loteprednol etabonate (substance) Is a Androstane true Inferred relationship Some
Loteprednol etabonate (substance) Is a Glucocorticoid (substance) true Inferred relationship Some
Loteprednol etabonate (substance) Is a Antilipemic agent (substance) true Inferred relationship Some
Loteprednol etabonate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Loteprednol etabonate ophthalmic preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Some
Loteprednol etabonate 5 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Some
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Some
Loteprednol etabonate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Some
Loteprednol etabonate + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Some
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Loteprednol etabonate (substance) Inferred relationship Some 1
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Loteprednol etabonate (substance) Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL eye suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Loteprednol etabonate (substance) Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL eye suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Loteprednol etabonate (substance) Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Loteprednol etabonate (substance) Inferred relationship Some 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Loteprednol etabonate (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start